Please login to the form below
President Trump
This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.
UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains
Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he
Latest news
-
Janet Woodcock named acting commissioner of the FDA
Under his leadership, the FDA was criticised by ex-President Trump over the agency’s timeline for approving COVID-19 vaccines. ... President Biden also began the process of reversing Trump's controversial decision to withdraw the US from the World
-
Pfizer, Sanofi and others set to increase US drug prices in 2021
Soaring drug prices had been a key issue for the Trump administration, with the outgoing US president issuing several executive orders in late 2020 aimed at lowering prices. ... Drug pricing will also be a focus of the incoming President-elect, Joe Biden,
-
WHO trial casts doubt on remdesivir's efficacy
Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he
-
Regeneron scores first FDA approval for Ebola antibody treatment
The antibody cocktail, REGN-COV2, was recently given to US president Donald Trump after he tested positive for coronavirus earlier this month.
-
Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail
The drug has been the focus of attention since reports confirmed that it had been given to US president Donald Trump after he tested positive for the novel coronavirus last week.
More from news
Approximately 7 fully matching, plus 83 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy
-
As COVID-19 takes over the world, biopharma fights back
19,” said George D Yancopoulos, co-founder, president and chief scientific officer of Regeneron. ... A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March
-
The Golden Goose
When President Trump complains of global ‘freeloaders’ in the drug trade, he is not completely off the mark. ... When efforts by the Trump administration to repeal and replace Obamacare lost momentum, it shifted to reducing drug costs.
-
The fight for affordable insulin
Where previous administrations were opposed to importation from Canada and elsewhere, the Trump White House says it is in favour of individuals resorting to these measures, but wants to legislate to ... Recent weeks have seen President Trump shift his
-
The Orkambi blame game
These included questions to Jeff Leiden about his salary, the company’s profits and taxes paid in the UK, and allegations from President Trump that European countries such as the UK
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Janssen’s single tablet combination shows promise in phase 3 PAH study
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- How to make sure your adverts for clinical trials are compliant
PMHub
fox&cat
Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
